Overall, a vast amount of ROS is produced via various chemical reactions
The medication's effect on bowel habits appears highly individualised, influenced by factors such as baseline gut function, dietary habits, hydration status, concurrent medications, and the specific dose being administered
52,53,54 Amino acid metabolites and short-chain fatty acid metabolites have been identified as specific biomarkers for UC, and leucine-rich 2-glycoprotein (LRG) has been developed as a serum biomarker of disease progression in UC patients
Many patients can successfully manage hair loss while continuing their medication by optimizing nutrition, slowing the rate of weight loss through dose adjustment, and adding hair-supportive treatments